Roanoke Asset Management Corp Eli Lilly & CO Transaction History

Roanoke Asset Management Corp

  • $318 Million
  • Q3 2024

A detailed history of Roanoke Asset Management Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Roanoke Asset Management Corp holds 12,237 shares of LLY stock, worth $9.4 Million. This represents 3.41% of its overall portfolio holdings.

Number of Shares
12,237
Previous 12,282 0.37%
Holding current value
$9.4 Million
Previous $11.1 Million 2.51%
% of portfolio
3.41%
Previous 3.67%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024
SELL
$772.14 - $960.02 $34,746 - $43,200
-45 Reduced 0.37%
12,237 $10.8 Million
Q2 2024

Aug 14, 2024
SELL
$724.87 - $909.04 $658,181 - $825,408
-908 Reduced 6.88%
12,282 $11.1 Million
Q1 2024

May 08, 2024
SELL
$592.2 - $792.28 $8,883 - $11,884
-15 Reduced 0.11%
13,190 $10.3 Million
Q4 2023

Feb 08, 2024
SELL
$525.19 - $619.13 $152,305 - $179,547
-290 Reduced 2.15%
13,205 $7.7 Million
Q3 2023

Nov 15, 2023
SELL
$434.7 - $599.3 $878,094 - $1.21 Million
-2,020 Reduced 13.02%
13,495 $7.25 Million
Q2 2023

Jul 31, 2023
SELL
$350.74 - $468.98 $17,537 - $23,449
-50 Reduced 0.32%
15,515 $7.28 Million
Q1 2023

May 02, 2023
SELL
$310.63 - $364.82 $3,106 - $3,648
-10 Reduced 0.06%
15,565 $5.35 Million
Q4 2022

Feb 08, 2023
SELL
$321.55 - $374.67 $334,412 - $389,656
-1,040 Reduced 6.26%
15,575 $5.7 Million
Q2 2022

Aug 10, 2022
SELL
$278.73 - $327.27 $770,688 - $904,901
-2,765 Reduced 14.27%
16,615 $5.39 Million
Q1 2022

May 11, 2022
SELL
$234.69 - $291.66 $408,360 - $507,488
-1,740 Reduced 8.24%
19,380 $5.55 Million
Q4 2021

Feb 09, 2022
SELL
$224.85 - $279.04 $104,330 - $129,474
-464 Reduced 2.15%
21,120 $5.83 Million
Q3 2021

Nov 03, 2021
SELL
$221.6 - $272.71 $24,376 - $29,998
-110 Reduced 0.51%
21,584 $4.99 Million
Q2 2021

Jul 28, 2021
BUY
$180.55 - $233.54 $852,196 - $1.1 Million
4,720 Added 27.81%
21,694 $4.98 Million
Q1 2021

May 14, 2021
SELL
$164.32 - $212.72 $3,286 - $4,254
-20 Reduced 0.12%
16,974 $3.17 Million
Q4 2020

Feb 12, 2021
SELL
$130.46 - $172.63 $31,310 - $41,431
-240 Reduced 1.39%
16,994 $2.87 Million
Q3 2020

Nov 12, 2020
SELL
$146.22 - $169.13 $285,860 - $330,649
-1,955 Reduced 10.19%
17,234 $2.55 Million
Q2 2020

Aug 05, 2020
SELL
$136.42 - $164.18 $369,971 - $445,256
-2,712 Reduced 12.38%
19,189 $3.15 Million
Q1 2020

May 13, 2020
SELL
$119.05 - $147.35 $14,881 - $18,418
-125 Reduced 0.57%
21,901 $3.04 Million
Q4 2019

Feb 05, 2020
SELL
$106.92 - $132.43 $565,927 - $700,951
-5,293 Reduced 19.37%
22,026 $2.9 Million
Q3 2019

Nov 01, 2019
SELL
$106.79 - $116.16 $87,567 - $95,251
-820 Reduced 2.91%
27,319 $3.06 Million
Q2 2019

Jul 19, 2019
SELL
$110.79 - $129.32 $24,373 - $28,450
-220 Reduced 0.78%
28,139 $3.12 Million
Q4 2018

Feb 06, 2019
SELL
$105.9 - $118.64 $40,771 - $45,676
-385 Reduced 1.34%
28,359 $3.28 Million
Q3 2018

Oct 30, 2018
SELL
$85.86 - $107.31 $1,287 - $1,609
-15 Reduced 0.05%
28,744 $3.08 Million
Q2 2018

Jul 25, 2018
SELL
$75.7 - $86.88 $130,279 - $149,520
-1,721 Reduced 5.65%
28,759 $2.45 Million
Q1 2018

Apr 19, 2018
SELL
$74.21 - $87.6 $69,386 - $81,906
-935 Reduced 2.98%
30,480 $2.36 Million
Q4 2017

Jan 29, 2018
SELL
$81.94 - $87.89 $439,198 - $471,090
-5,360 Reduced 14.58%
31,415 $2.65 Million
Q3 2017

Oct 20, 2017
BUY
$77.07 - $85.54 $2.83 Million - $3.15 Million
36,775
36,775 $3.15 Million

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
751M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Roanoke Asset Management Corp Portfolio

Follow Roanoke Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roanoke Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Roanoke Asset Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email